Novo Nordisk CFO: U.S. Obesity Market Must Emerge, But It Will Take Time

By: via Benzinga
Novo Nordisk A/S (ADR) (NYSE: NVO) came out with better-than-expected quarterly results earlier on Thursday. Revenue for the company ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.